צמיחת הכנסות ב-12 חודשים נגררים: Aprea Therapeutics (APRE)

How does a biotech's minimal environmental footprint impact operational resilience? Aprea Therapeutics (APRE) minimizes supply risks through the complete outsourcing of production to certified CMOs in the US. Annual revenue growth from sales over a rolling period is derived from GURU.Markets data on this chart, where -99.70 captures the value of this parameter, confirming the success of the development of DNA repair-based targeted therapy.
Aprea Therapeutics, Inc. - פילוחים אנליטיים ומדדי מפתח (APRE)

This indicator determines the pace of business expansion by measuring the percentage change in revenue over the last 12 months relative to the same period last year. By analyzing the trailing 12-month (TTM) sales dynamics on GURU.Markets, an investor assesses the life cycle stage of Aprea Therapeutics (APRE), where management transparency in drug development allows one to distinguish a temporary stagnation from the systemic decline of the company.